Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Monique Hanse"'
Autor:
Jan Willem B. de Groot, Johan A F Koekkoek, Docc investigators, Karlijn de Joode, Astrid A M van der Veldt, Martin J. van den Bent, Esther Oomen-de Hoop, Monique Hanse, Walter Taal, Anne-Marie C. Dingemans, Tom J. Snijders, Mathilde C.M. Kouwenhoven, Laurens V. Beerepoot
Publikováno v:
Neuro-Oncology
Neuro-Oncology, 24(2), 326-328. Oxford University Press
Neuro-oncology, 24(2), 326-328. Oxford University Press
de Joode, K, Taal, W, Snijders, T J, Hanse, M, Koekkoek, J A F, Oomen-de Hoop, E, de Groot, J W B, Kouwenhoven, M C M, Beerepoot, L V, Dingemans, A-M C, van den Bent, M J, van der Veldt, A A M & DOCC Investigators 2022, ' Patients with primary brain tumors and COVID-19 : A report from the Dutch Oncology COVID-19 Consortium ', Neuro-Oncology, vol. 24, no. 2, pp. 326-328 . https://doi.org/10.1093/neuonc/noab258
Neuro-Oncology, 24(2), 326-328. Oxford University Press
Neuro-oncology, 24(2), 326-328. Oxford University Press
de Joode, K, Taal, W, Snijders, T J, Hanse, M, Koekkoek, J A F, Oomen-de Hoop, E, de Groot, J W B, Kouwenhoven, M C M, Beerepoot, L V, Dingemans, A-M C, van den Bent, M J, van der Veldt, A A M & DOCC Investigators 2022, ' Patients with primary brain tumors and COVID-19 : A report from the Dutch Oncology COVID-19 Consortium ', Neuro-Oncology, vol. 24, no. 2, pp. 326-328 . https://doi.org/10.1093/neuonc/noab258
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ad89712092b48663a6993c8d4f3552a
https://pure.eur.nl/en/publications/e8c168f0-66ac-4c4d-bb88-427a5418d307
https://pure.eur.nl/en/publications/e8c168f0-66ac-4c4d-bb88-427a5418d307
Autor:
Youri Hoogstrate, Kaspar Draaisma, Santoesha A. Ghisai, Levi van Hijfte, Nastaran Barin, Iris de Heer, Wouter Coppieters, Thierry P.P. van den Bosch, Anne Bolleboom, Zhenyu Gao, Arnaud J.P.E. Vincent, Latifa Karim, Manon Deckers, Martin J.B. Taphoorn, Melissa Kerkhof, Astrid Weyerbrock, Marc Sanson, Ann Hoeben, Slávka Lukacova, Giuseppe Lombardi, Sieger Leenstra, Monique Hanse, Ruth E.M. Fleischeuer, Colin Watts, Nicos Angelopoulos, Thierry Gorlia, Vassilis Golfinopoulos, Vincent Bours, Martin J. van den Bent, Pierre A. Robe, Pim J. French
Publikováno v:
Cancer Cell, 41(4)
Cancer Cell, 41(4), 678-692.e7. Cell Press
Hoogstrate, Y, Draaisma, K, Ghisai, S A, van Hijfte, L, Barin, N, de Heer, I, Coppieters, W, van den Bosch, T P P, Bolleboom, A, Gao, Z, Vincent, A J P E, Karim, L, Deckers, M, Taphoorn, M J B, Kerkhof, M, Weyerbrock, A, Sanson, M, Hoeben, A, Lukacova, S, Lombardi, G, Leenstra, S, Hanse, M, Fleischeuer, R E M, Watts, C, Angelopoulos, N, Gorlia, T, Golfinopoulos, V, Bours, V, van den Bent, M J, Robe, P A & French, P J 2023, ' Transcriptome analysis reveals tumor microenvironment changes in glioblastoma ', Cancer Cell, vol. 41, no. 4, pp. 678-692.e7 . https://doi.org/10.1016/j.ccell.2023.02.019
Cancer Cell, 41(4), 678-692.e7. Cell Press
Hoogstrate, Y, Draaisma, K, Ghisai, S A, van Hijfte, L, Barin, N, de Heer, I, Coppieters, W, van den Bosch, T P P, Bolleboom, A, Gao, Z, Vincent, A J P E, Karim, L, Deckers, M, Taphoorn, M J B, Kerkhof, M, Weyerbrock, A, Sanson, M, Hoeben, A, Lukacova, S, Lombardi, G, Leenstra, S, Hanse, M, Fleischeuer, R E M, Watts, C, Angelopoulos, N, Gorlia, T, Golfinopoulos, V, Bours, V, van den Bent, M J, Robe, P A & French, P J 2023, ' Transcriptome analysis reveals tumor microenvironment changes in glioblastoma ', Cancer Cell, vol. 41, no. 4, pp. 678-692.e7 . https://doi.org/10.1016/j.ccell.2023.02.019
A better understanding of transcriptional evolution of IDH-wild-type glioblastoma may be crucial for treatment optimization. Here, we perform RNA sequencing (RNA-seq) (n = 322 test, n = 245 validation) on paired primary-recurrent glioblastoma resecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bb4d868c4967f080400fdfa01b352cb
https://doi.org/10.1016/j.ccell.2023.02.019
https://doi.org/10.1016/j.ccell.2023.02.019
Autor:
Renske Gahrmann, Marion Smits, René Michel Vernhout, Walter Taal, Giorgios Kapsas, Jan Cees de Groot, Monique Hanse, Maaike Vos, Laurens Victor Beerepoot, Jan Buter, Zwenneke Hendrieke Flach, Bronno van der Holt, Martin van den Bent
Publikováno v:
Gahrmann, R, Smits, M, Vernhout, R M, Taal, W, Kapsas, G, de Groot, J C, Hanse, M, Vos, M, Beerepoot, L V, Buter, J, Flach, Z H, van der Holt, B & van den Bent, M 2022, ' The impact of different volumetric thresholds to determine progressive disease in patients with recurrent glioblastoma treated with bevacizumab ', Neuro-oncology advances, vol. 4, no. 1, vdac032 . https://doi.org/10.1093/noajnl/vdac032
Neuro-Oncology Advances, 4(1):vdac032. Oxford University Press
Neuro-oncology advances, 4(1):vdac032. Oxford University Press
Neuro-oncology advances, 4(1):vdac032
Neuro-Oncology Advances, 4(1):vdac032. Oxford University Press
Neuro-oncology advances, 4(1):vdac032. Oxford University Press
Neuro-oncology advances, 4(1):vdac032
Background The optimal volumetric threshold for determining progressive disease (PD) in recurrent glioblastoma is yet to be determined. We investigated a range of thresholds in association with overall survival (OS). Methods First recurrent glioblast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b0f793e0e28d276a5980a90eead8efa
https://doi.org/10.1093/noajnl/vdac032
https://doi.org/10.1093/noajnl/vdac032
Autor:
Youri Hoogstrate, Santoesha Ghisai, Kaspar Draaisma, Vincent Bours, Jan Buter, Isabelle vanden Bempt, Marica Eoli, Enrico Franceschi, Jean-Sebastien Frenel, Thierry Gorlia, Monique Hanse, Ann Hoeben, Melissa Kerkhof, Johan Kros, Sieger Leenstra, Guiseppe Lombardi, Slávka Lukacova, Pierre Robe, Juan M. Sepulveda, Walter Taal, Martin Taphoorn, Annemiek M.E. Walenkamp, Colin Watts, Michael Weller, Filip Y.F. de Vos, Martin van den Bent, Pim French
Publikováno v:
WFNOS 2022 Abstract Book.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a21ef110a7c59f388375c8ccc9523928
https://doi.org/10.14791/btrt.2022.10.f-1098
https://doi.org/10.14791/btrt.2022.10.f-1098
Autor:
Meriam Braaksma, Karin Gehring, Geert-Jan Rutten, Elke Butterbrod, Monique Hanse, Jimme Bruijn, Cees C. Tijssen, Margriet M. Sitskoorn
Publikováno v:
Journal of Neuro-Oncology, 144(3), 511-518. Kluwer Academic Publishers
Journal of Neuro-Oncology
Journal of Neuro-Oncology
Purpose Progressive disease in patients with high-grade glioma may be reflected in cognitive decline. However, the cognitive functions most sensitive to progression may differ between patients. We investigated whether decline on a personalized select
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e3f3bad5507364e29c0708243384aa6
https://doi.org/10.1007/s11060-019-03249-1
https://doi.org/10.1007/s11060-019-03249-1
Autor:
Youri Hoogstrate, Kaspar Draaisma, Santoesha A. Ghisai, Iris de Heer, Levi van Hijfte, Wouter Coppieters, Melissa Kerkhof, Astrid Weyerbrock, Marc Sanson, Ann Hoeben, Slávka Lukacova, Giuseppe Lombardi, Sieger Leenstra, Monique Hanse, Ruth Fleischeuer, Colin Watts, Joseph McAbee, Nicos Angelopoulos, Thierry Gorlia, Vassilis Golfinopoulos, Johan M. Kros, Vincent Bours, Martin J. van den Bent, Pierre A. Robe, Pim J. French
Publikováno v:
Cancer Research. 82:6140-6140
Background: Glioblastoma is the most prevalent and severe type of malignant brain tumor in adults. Although the genetic make-up initiating glioblastoma is increasingly better understood, a better understanding in the mechanisms that drive its evoluti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bfb2abdf8f1981e52ef74540bb7c6791
https://doi.org/10.1158/1538-7445.am2022-6140
https://doi.org/10.1158/1538-7445.am2022-6140
Autor:
Johan A F Koekkoek, Cees C. Tijssen, Anja Gijtenbeek, Martin J B Taphoorn, Paul Bienfait, Linda Dirven, Marthe C.M. Peeters, Leonie van Leeuwen, Germaine Ottenheijm, Daniëlle B.P. Eekers, Monique Hanse
Publikováno v:
BMJ Supportive and Palliative Care. BMJ Publishing Group
BMJ Supportive & Palliative Care. BMJ PUBLISHING GROUP
BMJ Supportive & Palliative Care
BMJ Supportive & Palliative Care. BMJ PUBLISHING GROUP
BMJ Supportive & Palliative Care
IntroductionRoutine assessment of patient-reported outcomes (PROs) in oncology has shown to improve the quality of the delivered care and to prolong survival. However, for successful implementation of routine assessment of PROs, more knowledge on the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10732ddec31a45a76dca15c723750164
https://hdl.handle.net/1887/3251114
https://hdl.handle.net/1887/3251114
Autor:
Thierry Gorlia, Vincent Bours, Colin Watts, Roel G.W. Verhaak, Johan M. Kros, Giuseppe Lombardi, Sieger Leenstra, Pierre A. Robe, Joseph H. McAbee, Marc Sanson, Melissa Kerkhof, Nicos Angelopoulos, Martin J B Taphoorn, Pim J. French, Ann Hoeben, Ultan McDermott, Ruth Fleischeuer, Monique Hanse, Slavka Lukacova, Vassilis Golfinopoulos, Kaspar Draaisma, Martin J. van den Bent, Astrid Weyerbrock, Aikaterini Chatzipli
Publikováno v:
Journal of Clinical Oncology, 38(1), 81-99. American Society of Clinical Oncology
Draaisma, K, Chatzipli, A, Taphoorn, M, Kerkhof, M, Weyerbrock, A, Sanson, M, Hoeben, A, Lukacova, S, Lombardi, G, Leenstra, S, Hanse, M, Fleischeuer, R, Watts, C, McAbee, J, Angelopoulos, N, Gorlia, T, Golfinopoulos, V, Kros, J M, Verhaak, R G W, Bours, V, van den Bent, M J, McDermott, U, Robe, P A & French, P J 2020, ' Molecular evolution of IDH wild-type glioblastomas treated with standard of care affects survival and design of precision medicine trials : A report from the EORTC 1542 study ', Journal of Clinical Oncology, vol. 38, no. 1, pp. 81-99 . https://doi.org/10.1200/JCO.19.00367
Journal of Clinical Oncology, 38, 81-99. American Society of Clinical Oncology
Draaisma, K, Chatzipli, A, Taphoorn, M, Kerkhof, M, Weyerbrock, A, Sanson, M, Hoeben, A, Lukacova, S, Lombardi, G, Leenstra, S, Hanse, M, Fleischeuer, R, Watts, C, McAbee, J, Angelopoulos, N, Gorlia, T, Golfinopoulos, V, Kros, J M, Verhaak, R G W, Bours, V, van den Bent, M J, McDermott, U, Robe, P A & French, P J 2020, ' Molecular evolution of IDH wild-type glioblastomas treated with standard of care affects survival and design of precision medicine trials : A report from the EORTC 1542 study ', Journal of Clinical Oncology, vol. 38, no. 1, pp. 81-99 . https://doi.org/10.1200/JCO.19.00367
Journal of Clinical Oncology, 38, 81-99. American Society of Clinical Oncology
PURPOSE Precision medicine trials in glioblastoma (GBM) are often conducted at tumor recurrence. However, second surgeries for recurrent GBM are not routinely performed, and therefore, molecular data for trial inclusion are predominantly derived from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b889fbf7ea028fbd02206bb8ba440f70
https://cris.maastrichtuniversity.nl/en/publications/04973a2e-30ee-445c-8029-685ab2b01a63
https://cris.maastrichtuniversity.nl/en/publications/04973a2e-30ee-445c-8029-685ab2b01a63
Autor:
Neil K. Aaronson, Martin J B Taphoorn, Martin J. van den Bent, Corelien Kloek, Cees C. Tijssen, Karin Gehring, Monique Hanse, Geert-Jan Rutten, Martijn M. Stuiver, Margriet M. Sitskoorn, Eva Visser
Publikováno v:
Neuro-oncology, 2020(1), 103-115
Neuro-oncology, 22(1), 103-115. Oxford University Press
Neuro-Oncology, 22(1), 103-115. OXFORD UNIV PRESS INC
Neuro-Oncology, 22, 103-115. Oxford University Press
Neuro-Oncology
Neuro-oncology, 22(1). Oxford University Press
Neuro-oncology, 22(1), 103-115. Oxford University Press
Neuro-Oncology, 22(1), 103-115. OXFORD UNIV PRESS INC
Neuro-Oncology, 22, 103-115. Oxford University Press
Neuro-Oncology
Neuro-oncology, 22(1). Oxford University Press
Background Patients with glioma often suffer from cognitive deficits. Physical exercise has been effective in ameliorating cognitive deficits in older adults and neurological patients. This pilot randomized controlled trial (RCT) explored the possibl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b5bbfa06b0aa8276c0b23057c2b61a9
https://surfsharekit.nl/public/0ae53ad6-1039-470b-9964-91c5b97ae81f
https://surfsharekit.nl/public/0ae53ad6-1039-470b-9964-91c5b97ae81f
Autor:
Bronno van der Holt, Walter Taal, Zwenneke Hendrieke Flach, Monique Hanse, Bas Jasperse, Jan Buter, Martin J. van den Bent, René M. Vernhout, Marion Smits, Maaike J. Vos, Renske Gahrmann, Jan Cees de Groot, Laurens V. Beerepoot
Publikováno v:
Neuro-Oncology, 19(6), 853-861. Oxford University Press
Gahrmann, R, van den Bent, M, van der Holt, B, Vernhout, R M, Taal, W, Vos, M, de Groot, J C, Beerepoot, L V, Buter, J, Flach, Z H, Hanse, M, Jasperse, B & Smits, M 2017, ' Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab-a report from the BELOB trial ', Neuro-Oncology, vol. 19, no. 6, pp. 853-861 . https://doi.org/10.1093/neuonc/now311, https://doi.org/10.1093/neuonc/now311
Gahrmann, R, van den Bent, M, van der Holt, B, Vernhout, R M, Taal, W, Vos, M, de Groot, J C, Beerepoot, L V, Buter, J, Flach, Z H, Hanse, M, Jasperse, B & Smits, M 2017, ' Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab-a report from the BELOB trial ', Neuro-Oncology, vol. 19, no. 6, pp. 853-861 . https://doi.org/10.1093/neuonc/now311, https://doi.org/10.1093/neuonc/now311
Background. The current method for assessing progressive disease (PD) in glioblastoma is according to the Response Assessment in Neuro-Oncology (RANO) criteria. Bevacizumab-treated patients may show pseudo-response on postcontrast T1-weighted (T1w) M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca94a46a95cb942147567e228da7dcc3
https://doi.org/10.1093/neuonc/now311
https://doi.org/10.1093/neuonc/now311